Yoshida K - Search Results

1

E1AF degradation by a ubiquitin-proteasome pathway.

Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, Kobayashi M, Totsuka Y, Kohgo T, Shindoh M. Takahashi A, et al. Among authors: yoshida k. Biochem Biophys Res Commun. 2005 Feb 11;327(2):575-80. doi: 10.1016/j.bbrc.2004.12.045. Biochem Biophys Res Commun. 2005. PMID: 15629152

2

E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters.

Izumiyama Y, Ohiro Y, Higashino F, Yoshida K, Taguchi K, Todo S, Kohgo T, Totsuka Y, Shindoh M. Izumiyama Y, et al. Among authors: yoshida k. Oncol Rep. 2005 Apr;13(4):715-20. Oncol Rep. 2005. PMID: 15756447

3

Genomic structure and promoter activity of the E1AF gene, a member of the ETS oncogene family.

Ishida S, Higashino F, Aoyagi M, Takahashi A, Suzuki T, Shindoh M, Fujinaga K, Yoshida K. Ishida S, et al. Among authors: yoshida k. Biochem Biophys Res Commun. 2006 Jan 6;339(1):325-30. doi: 10.1016/j.bbrc.2005.11.024. Epub 2005 Nov 15. Biochem Biophys Res Commun. 2006. PMID: 16297865

4

Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.

Hata H, Kitamura T, Higashino F, Hida K, Yoshida K, Ohiro Y, Totsuka Y, Kitagawa Y, Shindoh M. Hata H, et al. Among authors: yoshida k. Oncol Rep. 2008 May;19(5):1093-8. Oncol Rep. 2008. PMID: 18425363

5

EWS/ETS fusions activate telomerase in Ewing's tumors.

Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, Kyo S, Ohno T, Taira T, Ariga H, Nakajima K, Hatta M, Kobayashi M, Sano H, Kohgo T, Shindoh M. Takahashi A, et al. Among authors: yoshida k. Cancer Res. 2003 Dec 1;63(23):8338-44. Cancer Res. 2003. PMID: 14678994

6

E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.

Hakuma N, Kinoshita I, Shimizu Y, Yamazaki K, Yoshida K, Nishimura M, Dosaka-Akita H. Hakuma N, et al. Among authors: yoshida k. Cancer Res. 2005 Dec 1;65(23):10776-82. doi: 10.1158/0008-5472.CAN-05-0060. Cancer Res. 2005. PMID: 16322223

7

E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen.

Iwasaki M, Nishikawa A, Akutagawa N, Fujimoto T, Teramoto M, Sakaguchi Y, Kato H, Ito M, Yoshida K, Kudo R. Iwasaki M, et al. Among authors: yoshida k. Exp Cell Res. 2004 Oct 1;299(2):525-32. doi: 10.1016/j.yexcr.2004.06.020. Exp Cell Res. 2004. PMID: 15350549

8

ZNRF1 interacts with tubulin and regulates cell morphogenesis.

Yoshida K, Watanabe M, Hatakeyama S. Yoshida K, et al. Biochem Biophys Res Commun. 2009 Nov 20;389(3):506-11. doi: 10.1016/j.bbrc.2009.09.011. Epub 2009 Sep 6. Biochem Biophys Res Commun. 2009. PMID: 19737534 Free article.

9

Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.

Yabe H, Fukuma M, Urano F, Yoshida K, Kato S, Toyama Y, Hata J, Umezawa A. Yabe H, et al. Among authors: yoshida k. Biochem Biophys Res Commun. 2002 Apr 26;293(1):61-71. doi: 10.1016/S0006-291X(02)00129-8. Biochem Biophys Res Commun. 2002. PMID: 12054564

10

MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif.

Okumura F, Yoshida K, Liang F, Hatakeyama S. Okumura F, et al. Among authors: yoshida k. Mol Cell Biochem. 2011 Jun;352(1-2):163-72. doi: 10.1007/s11010-011-0750-4. Epub 2011 Feb 27. Mol Cell Biochem. 2011. PMID: 21359963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,574 results

Search Page